Global patent index - EP 1066321 A2

EP 1066321 A2 2001-01-10 - FORMULATION HAVING A PAPILLOMA VIRUS-SPECIFIC PROTEIN, AND THE PRODUCTION AND USE THEREOF

Title (en)

FORMULATION HAVING A PAPILLOMA VIRUS-SPECIFIC PROTEIN, AND THE PRODUCTION AND USE THEREOF

Title (de)

FORMULIERUNG MIT PAPILLOMAVIRUS-SPEZIFISCHEM PROTEIN, SEINE HERSTELLUNG UND VERWENDUNG

Title (fr)

FORMULATION CONTENANT UNE PROTEINE SPECIFIQUE DES PAPILLOMAVIRUS, SA FABRICATION ET SON UTILISATION

Publication

EP 1066321 A2 (DE)

Application

EP 99917850 A

Priority

  • DE 19812940 A
  • EP 9901999 W

Abstract (en)

[origin: DE19812940A1] The invention relates to a formulation containing at least one papilloma virus-specific protein with approximately 0.3 to approximately 4 M of a salt with a pH value of approximately 7.3 to approximately 7.45.

IPC 1-7 (main, further and additional classification)

C07K 14/025; A61K 39/12; G01N 33/569

IPC 8 full level (invention and additional information)

A61K 38/16 (2006.01); A61K 39/12 (2006.01); A61P 31/20 (2006.01); A61P 35/00 (2006.01); C07K 14/025 (2006.01); C12N 15/09 (2006.01); G01N 33/569 (2006.01)

CPC (invention and additional information)

G01N 33/56983 (2013.01); A61K 38/162 (2013.01)

Citation (search report)

See references of WO 9948917A3

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

EPO simple patent family

DE 19812940 A1 19991007; AR 014969 A1 20010411; AU 3598999 A 19991018; CA 2323526 A1 19990930; EP 1066321 A2 20010110; JP 2002507625 A 20020312; MX PA00009283 A 20021213; WO 9948917 A2 19990930; WO 9948917 A3 19991209

INPADOC legal status

2005-04-13 [18D] DEEMED TO BE WITHDRAWN

- Ref Legal Event Code: 18D

- Effective date: 20041001

2001-01-10 [17P] REQUEST FOR EXAMINATION FILED

- Ref Legal Event Code: 17P

- Effective date: 20001024

2001-01-10 [AK] DESIGNATED CONTRACTING STATES:

- Ref Legal Event Code: AK

- Designated State(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE